Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11680948 Detection and quantification of natalizumab
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Current Assignee
Abreos Biosciences
0
Date Filed
August 11, 2017
0
Date of Patent
June 20, 2023
0
Patent Applicant
Abreos Biosciences
0
Patent Application Number
16324878
0
Patent Citations
US Patent D757040 Display screen with animated graphical user interface
0
US Patent 9329187 Immunogenicity Assay
0
US Patent D766936 Display screen or portion thereof with icon
0
US Patent D771072 Display screen or portion thereof with graphical user interface
0
US Patent D774205 Diagnostic device
0
US Patent D780188 Display screen or portion thereof with graphical user interface
0
US Patent D798316 Display screen with graphical user interface
0
US Patent D804498 Display screen with graphical user interface
0
US Patent D805526 Display screen portion with animated graphical user interface
0
US Patent D805527 Display screen portion with animated graphical user interface
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11680948
0
Patent Primary Examiner
Ellen J Marcsisin
0
CPC Code
G01N 33/6854
0
G01N 2333/70546
0
C07K 7/08
0
Find more entities like US Patent 11680948 Detection and quantification of natalizumab
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE